Lingjiao Wu

3.1k total citations
31 papers, 608 citations indexed

About

Lingjiao Wu is a scholar working on Molecular Biology, Molecular Medicine and Cancer Research. According to data from OpenAlex, Lingjiao Wu has authored 31 papers receiving a total of 608 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 5 papers in Molecular Medicine and 5 papers in Cancer Research. Recurrent topics in Lingjiao Wu's work include Antibiotic Resistance in Bacteria (5 papers), MicroRNA in disease regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Lingjiao Wu is often cited by papers focused on Antibiotic Resistance in Bacteria (5 papers), MicroRNA in disease regulation (3 papers) and Cancer-related molecular mechanisms research (3 papers). Lingjiao Wu collaborates with scholars based in China, United States and United Kingdom. Lingjiao Wu's co-authors include Fusheng Wu, Qiangfeng Wang, Zeran Yang, Xiuming Zhu, Rong Yang, Jie Xu, Jian Yao, Beiwen Zheng, Shusen Zheng and Guohong Li and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Biochemical and Biophysical Research Communications.

In The Last Decade

Lingjiao Wu

27 papers receiving 606 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lingjiao Wu China 12 414 237 67 62 41 31 608
Chunhong Feng China 14 353 0.9× 175 0.7× 154 2.3× 55 0.9× 51 1.2× 23 570
Hongliang Yang China 14 237 0.6× 90 0.4× 54 0.8× 55 0.9× 27 0.7× 57 572
Ruibing Yang China 8 257 0.6× 74 0.3× 41 0.6× 28 0.5× 34 0.8× 13 436
Xingmei Liu China 13 204 0.5× 111 0.5× 50 0.7× 26 0.4× 40 1.0× 21 425
Vindhya Palagani Germany 9 257 0.6× 72 0.3× 58 0.9× 90 1.5× 133 3.2× 9 481
Tapas Patra United States 14 211 0.5× 58 0.2× 80 1.2× 166 2.7× 19 0.5× 29 559
Khalil Azizian Iran 10 260 0.6× 43 0.2× 56 0.8× 60 1.0× 31 0.8× 26 464
Su Jin Park South Korea 14 336 0.8× 173 0.7× 178 2.7× 113 1.8× 152 3.7× 36 816

Countries citing papers authored by Lingjiao Wu

Since Specialization
Citations

This map shows the geographic impact of Lingjiao Wu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lingjiao Wu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lingjiao Wu more than expected).

Fields of papers citing papers by Lingjiao Wu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lingjiao Wu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lingjiao Wu. The network helps show where Lingjiao Wu may publish in the future.

Co-authorship network of co-authors of Lingjiao Wu

This figure shows the co-authorship network connecting the top 25 collaborators of Lingjiao Wu. A scholar is included among the top collaborators of Lingjiao Wu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lingjiao Wu. Lingjiao Wu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Linzhi, et al.. (2025). Rapid-release and user-friendly costunolide/dehydrocostuslactone hydrophilic nanofibers: Therapeutic effects on acute gastric ulcers. International Journal of Pharmaceutics. 670. 125194–125194.
2.
Zhou, Jiawei, et al.. (2025). IS26-mediated cointegration generates a plasmid co-harbouring blaIMP-4 and blaKPC-2 in Klebsiella pneumoniae. Journal of Global Antimicrobial Resistance. 42. 61–65.
3.
Li, Linzhi, et al.. (2024). A gel plaster in the form of nipple cover: A comfortable and safe transdermal delivery method for mammary hyperplasia. International Journal of Pharmaceutics. 662. 124500–124500.
5.
Chen, Jing, et al.. (2022). Establishment of three heterogeneous subtypes and a risk model of low-grade gliomas based on cell senescence-related genes. Frontiers in Immunology. 13. 982033–982033. 4 indexed citations
6.
Chen, Chunlei, Hao Xu, Ruishan Liu, et al.. (2022). Emergence of Neonatal Sepsis Caused by MCR-9- and NDM-1-Co-Producing Enterobacter hormaechei in China. Frontiers in Cellular and Infection Microbiology. 12. 879409–879409. 9 indexed citations
7.
Ni, Lin, Rebeca Carballar‐Lejarazú, Weihong Sun, et al.. (2019). Comparative transcriptome among Euscaphis konishii Hayata tissues and analysis of genes involved in flavonoid biosynthesis and accumulation. BMC Genomics. 20(1). 24–24. 32 indexed citations
8.
Fan, Weina, et al.. (2018). Esophageal metastasis from endometrial adenocarcinoma: a case report and literature review. Translational Cancer Research. 7(4). 1178–1183. 2 indexed citations
9.
Carballar‐Lejarazú, Rebeca, Lingjiao Wu, Weihong Sun, et al.. (2018). Selection and evaluation of reference genes for qRT-PCR analysis in Euscaphis konishii Hayata based on transcriptome data. Plant Methods. 14(1). 42–42. 39 indexed citations
10.
Wu, Lingjiao, Jing Chen, Li Wang, & Zhe Wu. (2018). Whole genome sequence of an MCR-1-carrying, extended-spectrum β-lactamase (ESBL)-producing Escherichia coli ST746 isolate recovered from a community-acquired urinary tract infection. Journal of Global Antimicrobial Resistance. 13. 171–173. 8 indexed citations
11.
Liu, Zhikun, Qianwei Ye, Lingjiao Wu, et al.. (2018). Metallothionein 1 family profiling identifies MT1X as a tumor suppressor involved in the progression and metastastatic capacity of hepatocellular carcinoma. Molecular Carcinogenesis. 57(11). 1435–1444. 29 indexed citations
13.
Qin, Nan, Beiwen Zheng, Jian Yao, et al.. (2015). Influence of H7N9 virus infection and associated treatment on human gut microbiota. Scientific Reports. 5(1). 14771–14771. 93 indexed citations
14.
Wu, Lingjiao, Qiangfeng Wang, Jian Yao, et al.. (2014). MicroRNA let-7g and let-7i inhibit hepatoma cell growth concurrently via downregulation of the anti-apoptotic protein B-cell lymphoma-extra large. Oncology Letters. 9(1). 213–218. 30 indexed citations
15.
Yang, Zeran, Lingjiao Wu, Xiuming Zhu, et al.. (2013). MiR-29a modulates the angiogenic properties of human endothelial cells. Biochemical and Biophysical Research Communications. 434(1). 143–149. 47 indexed citations
16.
Wu, Lingjiao, et al.. (2012). Peripheral blood mononuclear cells inhibit proliferation and promote apoptosis of HeLa cells following stimulation with Bacillus Calmette-Guerin. Experimental and Therapeutic Medicine. 5(2). 561–566. 6 indexed citations
17.
Wu, Huiling, et al.. (2009). A New Procedure for Treating a Sebaceous Cyst: Removal of the Cyst Content with a Laser Punch and the Cyst Wall with a Minimal Postponed Excision. Aesthetic Plastic Surgery. 33(4). 597–599. 12 indexed citations
18.
Yang, Yunmei, Zherong Xu, Lingjiao Wu, & Weidong Huang. (2007). Study of Resistin gene expression in peripheral blood mononuclear cell and its gene polymorphism in a small range population. Journal of Zhejiang University SCIENCE B. 8(2). 132–135. 5 indexed citations
19.
Wu, Fusheng, Shusen Zheng, Lingjiao Wu, et al.. (2006). [Study on the prognostic value of hepatocyte growth factor and c-met for patients with hepatocellular carcinoma].. PubMed. 44(9). 603–8. 13 indexed citations
20.
Yang, Yunmei, Xueying Lv, Weidong Huang, Zherong Xu, & Lingjiao Wu. (2005). Study of androgen and atherosclerosis in old-age male. Journal of Zhejiang University SCIENCE A. 6B(9). 931–935. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026